A consortium of VC firms, led by listed investor Arix Bioscience, has taken part in a €20m series-A funding round for Danish biotechnology firm Stipe Therapeutics.
Fund, which has already been invested in at least one transaction, has a €1bn target
Pechel, via Pechel IV, and the co-investment team of Omnes back the French IT services firm
Connection Capital provided £6.7m to support the buyout of the business in 2017
Temasek previously led a £7m investment for the technology developer in 2016